131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients

Clinical trial NCT02602067 · TERMINATED

Trial details

NCT number: NCT02602067
Sponsor: sigma-tau i.f.r. S.p.A.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasm Head and Neck Neoplasm Skin Neoplasm Respiratory Tract Neoplasm Urogenital Neoplasm Digestive System Neoplasm Pancreatic Neoplasm Connective and Soft Tissue Neoplasm Lymphoma, Non-Hodgkin

Start date: 2015-11-01
Primary completion: 2017-04-30
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.